David A. Ramsay
2011
In 2011, David A. Ramsay earned a total compensation of $459.9K as Vice President and Chief Financial Officer at Halozyme Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $56,252 |
|---|---|
| Option Awards | $80,057 |
| Salary | $253,351 |
| Stock Awards | $62,531 |
| Other | $7,712 |
| Total | $459,903 |
Ramsay received $253.4K in salary, accounting for 55% of the total pay in 2011.
Ramsay also received $56.3K in non-equity incentive plan, $80.1K in option awards, $62.5K in stock awards and $7.7K in other compensation.
Rankings
In 2011, David A. Ramsay's compensation ranked 8,313th out of 10,747 executives tracked by ExecPay. In other words, Ramsay earned more than 22.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,313 out of 10,747 | 23rd |
Division Manufacturing | 3,059 out of 3,960 | 23rd |
Major group Chemicals And Allied Products | 766 out of 1,033 | 26th |
Industry group Drugs | 553 out of 781 | 29th |
Industry Biological Products, Except Diagnostic Substances | 94 out of 157 | 40th |
Source: SEC filing on April 7, 2014.
Ramsay's colleagues
We found six more compensation records of executives who worked with David A. Ramsay at Halozyme Therapeutics in 2011.
2011
James Shaffer
Halozyme Therapeutics
Vice President and Chief Commercial Officer
2011
Jean Liu
Halozyme Therapeutics
General Counsel
2011
Kurt Gustafson
Halozyme Therapeutics
Chief Financial Officer
2011
William Fallon
Halozyme Therapeutics
Vice President, Manufacturing & Operations
2011
H Shepard
Halozyme Therapeutics
Chief Scientific Officer
2011
Gregory Frost
Halozyme Therapeutics